(Body surface, map or mapping) and (BSM-STUDY Disopyramide)

Acta Cardiol 1996;51(5):381-94.
Application of mapping of cardiac electrical activity to the pharmacology.
D'Alche EP,
Universite, Caen, France.

J Cardiovasc Electrophysiol 1999 May;10(5):670-9.
Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation.
Kubara I, Ikeda H, Hiraki T, Yoshida T, Ohga M, Imaizumi T,
Department of Internal Medicine III and the Cardiovascular Research Institute, Kurume University School of Medicine, Japan.

J Cardiovasc Electrophysiol 2000 Apr;11(4):396-404.
Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms.
Shimizu W, Matsuo K, Takagi M, Tanabe Y, Aiba T, Taguchi A, Suyama K, Kurita T, Aihara N, Kamakura S,
Department of Internal Medicine, National Cardiovascular Center, Suita, Osaka, Japan. wshimizu@hsp.ncvc.go.jp

[Body Surface Maps] [Digital ECG Literature] [Home]